Raleigh, NC – According to filings with the U.S. Securities and Exchange Commission, Bryn Pharma is raising $17.5 Million in new funding. Sources indicate as part of senior management President, Steven Hartman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Bryn Pharma

Bryn Pharma was founded by patients who are personally affected by anaphylaxis. The concerns of patients and caregivers like us have informed our approach. Our experience has fueled our drive to find A Better Way. We are creating a practical solution to help our community better manage their daily lives with severe allergies. Our mission is simple to empower patients with a life-saving device that is small enough to comfortably fit in your pocket and easy to use in the event of an anaphylactic attack.

To learn more about Bryn Pharma, visit http://www.brynpharma.com/

Contact:
Steven Hartman, President
shartman@brynpharma.com
https://www.linkedin.com/in/steven-hartman-025960113/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved